Dr. (Ms) T.Theivasanthi of Kalasalingam University doing research in nanomaterials / nanotechnology; has 15 years of teaching experience; published many research articles/ books and h-index 10; winner of Publons Global Top Peer Reviewer Award-2018; reviewer in SERB (Dept. of Science & Tech, Govt. of India); life member of Indian Science Congress Association and Magnetics Society of India; member of International Association of Advanced Materials; serving as Editorial Board Member/ reviewer for some scientific journals; lead editor in JNNN special issue (SAGE Publications, UK); achieved many awards/ honours/ recognitions including - Madurai Women Achievers Award - 2013, Motivational Award - 2015 and 2015 Women’s Day Award of St.Annes College; achieved World Record in LIMCA Book of Records-2015 for nanotechnology invention “World’s first superparamagnetic plants materials” – named “Santhi Particles”.

silver, copper, lead, nanopowder, XRD, semiconductor, superparamagnetism, Electrolysis, graphene, bio-sensors, nano-biofertilizers, fertility, microbial fuel cells, nanocellulose, metal-polymer nanocomposites, solar cells, neutrino detection, satellite

Seyed Ali Ravanfar is currently working as a Biological Scientist at the University of Florida/Citrus Research and Education Center where his work focuses on genetic improvement of citrus and murraya relation to disease resistance. Prior to this role he was a Postdoctoral Researcher at the University of Florida, where his research was conducted chemical mutagenesis, RNAi suppression, CRISPR/Cas9 and targeted genome editing of sugarcane.

Research interest in plant biotechnology focuses on in vitro technology, genetic transformation and genome editing. He is active in publishing his research findings in journals of international repute.

Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia. Dr Suchkov is a Co-Supervisor over the Russian-American Agreement on scientific and clinical collaboration in the field of ocular immunology between Russian Academy of Sciences and National Institutes of Health (NIH); in 1991-1995 – a member of The Reciprocal Exchange Fellowship Program between Russian Immunological Society and British Society for Immunology. Dr Suchkov is a member of the Editorial Boards of many international journals including EPMA Journal (Springer, Brussels) and “Personalized Medicine Universe” (Elsevier, Japan).

Immunology

Marietjie is the founder and Managing Director of Biolawgic, a private company focussing on the promotion of bioethics and a Director at Dyason Inc in Pretoria where she specialises in Health-tech, Fin-tech and Bio-tech Contracts, Biotechnology Law, Health Care and Life Sciences Law and Insurance Litigation. Marietjie is particularly interested in and passionate about genetic, genomic and stem cell research and has published numerous articles in both national and international journals on these topics.

interested in genetic, genomic and stem cell research.

Dr Abbas Amini is currently an assistant professor at ACK and Western Sydney University, Australia. After obtaining PhD from the Hong Kong University of Science and Technology (ranked 17th in Engineering among the universities worldwide), he conducted research with Australian universities, as a postdoctoral research fellow at Monash and Deakin Universities, and as a senior research fellow at the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas is the editor of more than 20 reputed journals, and served as the chair/committee member of more than 120 international conferences to date.

Dr Amini's research focus in particular covers a wide range of multidisciplinary aspects: biomedical materials, bioplastics, shape memory alloys, water treatment, drug delivery systems, piezoelectric materials, graphene, graphane, CNTs, biodegradable polymeric nano-composites, TiO2, ZnO, environmental sustainability and water efficiency, experimental analysis, multi-scale (nano to macro) modelling of multi-physics phenomena, indentation methods, 3D printing, phase transition, mechanics of materials, fabrication of modern composites, manufacturing, offshore naval structures, and ship design.

Betty Lee has a PhD from Dartmouth Medical School, USA and MS in Clinical Chemistry from the University of Windsor, Canada. She has done her second MS Biochemistry from LSU Medical Center, USA. She completed her Post-doctoral training at the National Institutes of Health, USA. She is currently working as a Licensing Officer with the US government. She educates industries and academia about the Export Administration Regulations (EAR) and participates in outreach. In addition, she participated in the policy review of the Executive Order titled “Optimizing the security of biological select agents and toxins in the United States” signed by President Obama on July 2, 2010.

Betty Lee research interest focuses on Biochemistry, clinical chemistry, Biotechnology, Bioinformatics and systems biology